XERS:NASDAQ, Xeris Biopharma Holdings, Inc.

XERS stock overview

Xeris Biopharma Holdings, Inc. (XERS:NASDAQ) closed at $10.20 on October 23, 2026, down 6.08% on the day. The stock trades 10.7% below its 52-week high of $11.42 and 94.3% above its 52-week low of $5.25. Over the past year, it gained 10.7%. Xeris Biopharma Holdings, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$10.20
Day change
-6.08%
Volume
2,366,201
Average volume
2,285,503
Market cap
1B+
52-week range
$5.25 – $11.42
50-day average
$9.08
200-day average
$7.42

Price action over the past year

In 252 trading sessions since October 23, 2025, XERS closed higher on 128 days (51%). Its best day was January 8, 2026 (+12.76%) and its worst was November 6, 2025 (-21.88%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

XERS news

About Xeris Biopharma Holdings, Inc.

Xeris Pharmaceuticals Inc is a specialty pharmaceutical company leveraging its novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations.

Similar stocks

Find more stocks like XERS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.